Compare Stocks

→ Your eBook: Mastering Earnings Announcements Trading (From StockEarnings) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
FWAA Fifth Wall Acquisition Corp. I	$2.47 +1.2%	$12.40	$9.77 ▼ $12.92	$87.80M	N/A	368,485 shs	1.24 million shs
LVTX LAVA Therapeutics	$2.91 -0.7%	$2.64	$1.13 ▼ $6.47	N/A	0.64	1.57 million shs	63,821 shs
SVFB SVF Investment Corp. 2	$10.21	$10.20	$9.75 ▼ $10.41	$301.30M	0.03	92,790 shs	3,300 shs
VHAQ Viveon Health Acquisition	$9.00	$8.78	$0.00 ▼ $12.48	$59.85M	-0.06	6 shs	N/A

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
FWAA Fifth Wall Acquisition Corp. I	0.00%	-6.15%	-9.63%	-12.23%	-0.81%
LVTX LAVA Therapeutics	-6.39%	-0.68%	-0.68%	+77.58%	+64.61%
SVFB SVF Investment Corp. 2	0.00%	0.00%	0.00%	0.00%	0.00%
VHAQ Viveon Health Acquisition	0.00%	0.00%	+499,900.00%	-20.98%	-17.73%

Your eBook: Mastering Earnings Announcements Trading (Ad)

Trading around earnings announcements (Pre-Earnings, Into-Earnings, and Post-Earnings) provides a unique trading opportunity. That is because trading around earnings announcements presents short-term trading opportunities (these are great because they don’t tie your money up for very long).

Click Here to Claim Your FREE The Ultimate Strategy Guide To Trade Earnings E-Book .

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
FWAA Fifth Wall Acquisition Corp. I	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
LVTX LAVA Therapeutics	2.5811 of 5 stars	3.5	5.0	0.0	0.0	3.0	0.0	0.6
SVFB SVF Investment Corp. 2	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VHAQ Viveon Health Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
FWAA Fifth Wall Acquisition Corp. I	N/A	N/A	N/A	N/A
LVTX LAVA Therapeutics	3.00	Buy	$6.00	106.19% Upside
SVFB SVF Investment Corp. 2	N/A	N/A	N/A	N/A
VHAQ Viveon Health Acquisition	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest LVTX, FWAA, SVFB, and VHAQ Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
3/21/2024	LVTX LAVA Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$6.00

(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
FWAA Fifth Wall Acquisition Corp. I	N/A	N/A	N/A	N/A	$0.14 per share	N/A
LVTX LAVA Therapeutics	$6.77M	N/A	N/A	N/A	$3.39 per share	N/A
SVFB SVF Investment Corp. 2	N/A	N/A	N/A	N/A	($0.26) per share	N/A
VHAQ Viveon Health Acquisition	N/A	N/A	N/A	N/A	($3.22) per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
FWAA Fifth Wall Acquisition Corp. I	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
LVTX LAVA Therapeutics	-$41.97M	-$1.59	N/A	N/A	N/A	-620.09%	-68.54%	-35.68%	6/13/2024 (Estimated)
SVFB SVF Investment Corp. 2	-$1.03M	N/A	0.00	∞	N/A	N/A	-1.63%	0.05%	N/A
VHAQ Viveon Health Acquisition	-$610K	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A

Latest LVTX, FWAA, SVFB, and VHAQ Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/20/2024	Q4 2023	LVTX LAVA Therapeutics	$0.16	-$0.24	-$0.40	-$0.24	$25.00 million	$0.35 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
FWAA Fifth Wall Acquisition Corp. I	N/A	N/A	N/A	N/A	N/A
LVTX LAVA Therapeutics	N/A	N/A	N/A	N/A	N/A
SVFB SVF Investment Corp. 2	N/A	N/A	N/A	N/A	N/A
VHAQ Viveon Health Acquisition	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
FWAA Fifth Wall Acquisition Corp. I	N/A	0.78	0.78
LVTX LAVA Therapeutics	0.01	6.62	6.62
SVFB SVF Investment Corp. 2	N/A	2.66	2.66
VHAQ Viveon Health Acquisition	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
FWAA Fifth Wall Acquisition Corp. I	87.66%
LVTX LAVA Therapeutics	N/A
SVFB SVF Investment Corp. 2	71.02%
VHAQ Viveon Health Acquisition	22.14%

Insider Ownership

Company	Insider Ownership
FWAA Fifth Wall Acquisition Corp. I	N/A
LVTX LAVA Therapeutics	0.79%
SVFB SVF Investment Corp. 2	19.50%
VHAQ Viveon Health Acquisition	75.27%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
FWAA Fifth Wall Acquisition Corp. I	2	35.55 million	N/A	Not Optionable
LVTX LAVA Therapeutics	69	N/A	N/A	Optionable
SVFB SVF Investment Corp. 2	2	29.51 million	23.76 million	Not Optionable
VHAQ Viveon Health Acquisition	N/A	6.65 million	1.64 million	Not Optionable

LVTX, FWAA, SVFB, and VHAQ Headlines

Source	Headline
	Viveon Health Acquisition Corp.: Viveon Healthcare Acquisition Corp. Confirms Commitment To Proceed With Business Combination Process finanznachrichten.de - February 28 at 3:42 PM
	VIVEON HEALTHCARE ACQUISITION CORP. CONFIRMS COMMITMENT TO PROCEED WITH BUSINESS COMBINATION PROCESS globenewswire.com - February 27 at 4:45 PM
	NYSE American to Suspend Trading in Viveon Health Acquisition Corp. (VHAQ) finance.yahoo.com - February 21 at 7:40 PM
	Viveon Health Acquisition Corp. Receives Commencement of Delisting Notice From the NYSE finance.yahoo.com - December 27 at 7:32 PM
	NYSE American to Commence Delisting Proceedings Against Viveon Health Acquisition Corp. (VHAQ) tmcnet.com - December 22 at 6:29 PM
	San Antonio, Texas Clearday (CLRD-OTCQX) is proud to honor our US Veterans through the Company’s Clearday Club in San Antonio, Texas. finance.yahoo.com - November 13 at 8:17 PM
	NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Viveon Health Acquisition Corp. (VHAQ.WS) finance.yahoo.com - October 24 at 12:34 PM
	VHAQ-R Viveon Health Acquisition Corp. seekingalpha.com - September 23 at 7:56 AM
	Viveon Health Acquisition Received Audit Opinion With Going Concern Explanation marketwatch.com - September 15 at 6:11 PM
	VIVEON HEALTH ACQUISITION CORP. RECEIVED AUDIT OPINION WITH GOING CONCERN EXPLANATION finance.yahoo.com - September 15 at 6:11 PM
	Viveon Healthcare Increases Consideration Offered to Clearday Shareholders finance.yahoo.com - September 5 at 6:45 PM
	SPAC Viveon ups merger consideration for Clearday to $500M msn.com - August 29 at 4:18 PM
	Viveon Health Acquisition Corp. and Clearday, Inc. Announce Amendment to their Definitive Merger Agreement finance.yahoo.com - August 29 at 4:18 PM
	VIVEON HEALTH ACQUISITION CORP. RECEIVES NYSE NOTICE REGARDING DELAYED FORM 10-K FILING finance.yahoo.com - April 25 at 9:05 PM
	Viveon Health Acquisition Corp. (VHAQ-RT) finance.yahoo.com - April 18 at 3:32 PM
	(Updated) Clearday Inc. and Viveon Health Acquisition Corp. Announce Definitive Merger Agreement to Accelerate Innovative Longevity-Tech Platform to Market finance.yahoo.com - April 12 at 12:15 PM
	SPAC Viveon to merge with senior-care tech provider Clearday seekingalpha.com - April 6 at 1:59 PM
	SPAC Viveon signs merger LOI with health monitoring platform Clearday msn.com - March 1 at 2:48 PM
	Viveon Health Acquisition Corp. and Clearday Inc. Announce Signed Letter of Intent to Merge and Create a Leading Longevity Care Company finance.yahoo.com - March 1 at 9:48 AM
	SPAC Viveon terminates planned merger with Suneva Medical msn.com - February 6 at 6:48 PM
	Viveon Health Acquisition Corp. Announces Termination of Merger Agreement with Suneva Medical, Inc. finance.yahoo.com - February 3 at 12:53 PM
	VIVEON HEALTH ACQUISITION CORP. Announces Adjournment of Special Meeting in Connection with ... kentuckytoday.com - January 27 at 10:07 AM
	SPAC Viveon Health delays Suneva merger vote amid cash issues msn.com - January 25 at 2:25 PM
	VIVEON HEALTH ACQUISITION CORP. Announces Adjournment of Special Meeting in Connection with Vote to Consummate its Initial Business Combination with Suneva Medical, Inc. Until February 3, 2023. finance.yahoo.com - January 25 at 2:25 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Fifth Wall Acquisition Corp. I

NASDAQ:FWAA

Fifth Wall Acquisition Corp. I focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded in 2020 and is based in Los Angeles, California.

LAVA Therapeutics

NASDAQ:LVTX

LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer patients. Its lead clinical-stage candidates are LAVA-1207 that is in Phase 1/2a clinical trial for metastatic castration-resistant prostate cancer. The company is developing other Gammabody drug candidates, which include LAVA-1223, which targets the epidermal growth factor receptor (EGFR) for the treatment of selected solid tumors, as well as LAVA-1266 which are preclinical candidates for the treatment of various hematologic malignancies. LAVA Therapeutics N.V. has a research collaboration and license agreement with Janssen Biotech, Inc. for the potential discovery and development of multi-specific antibody products that are directed to a specified target in various fields of use; and a collaboration with Merck & Co., Inc. to evaluate anti-PD-1 therapy KEYTRUDA in combination with LAVA-1207. LAVA Therapeutics N.V. was incorporated in 2016 and is headquartered in Utrecht, the Netherlands.

SVF Investment Corp. 2

NASDAQ:SVFB

SVF Investment Corp. 2 does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify, acquire, and manage a business in a technology-enabled sector. The company was formerly known as SVF Investment II Corp. and changed its name to SVF Investment Corp. 2. in January 2021. SVF Investment Corp. 2 was incorporated in 2020 and is based in San Carlos, California.

Viveon Health Acquisition

NYSE:VHAQ

Viveon Health Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was incorporated in 2020 and is based in Atlanta, Georgia. Viveon Health Acquisition Corp. operates as a subsidiary of Viveon Health LLC.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial